MOSCOW, January 4. /TASS/. Geropharm, a Russian pharmaceutical company, has filed document for clinical trials of ultra long-acting insulin, Deputy Prime Minister Denis Manturov told TASS in an interview.

Such drug will be needed to be used not more than once a week.

"This [submission of documents] took place literally several days before. This is a unique drug providing for one-time introduction for a week. There are no peers at the moment. I am aware that foreign pharmaceutical producers are carrying their activities. I am confident Geropharm will succeed. It is currently among leaders in diabetes control sphere," the official said.

Geropharm has already completed early development and preclinical trials of the drug, the company said earlier.